112 related articles for article (PubMed ID: 9288842)
1. Analysis of risk factors for mandibular bone radionecrosis after exclusive low dose-rate brachytherapy for oral cancer.
Lozza L; Cerrotta A; Gardani G; De Marie M; Di Russo A; Kenda R; Tana S; Valvo F; Zucali R
Radiother Oncol; 1997 Aug; 44(2):143-7. PubMed ID: 9288842
[TBL] [Abstract][Full Text] [Related]
2. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
[TBL] [Abstract][Full Text] [Related]
3. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth.
Simon JM; Mazeron JJ; Pohar S; Le Péchoux C; Crook JM; Grimard L; Piedbois P; Le Bourgeois JP; Pierquin B
Radiother Oncol; 1993 Jan; 26(1):19-25. PubMed ID: 8438082
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
Lee IJ; Koom WS; Lee CG; Kim YB; Yoo SW; Keum KC; Kim GE; Choi EC; Cha IH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1084-91. PubMed ID: 19327914
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer.
Miura M; Takeda M; Sasaki T; Inoue T; Nakayama T; Fukuda H; Hoshi A; Hoshina M; Shibuya H
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):763-70. PubMed ID: 9652836
[TBL] [Abstract][Full Text] [Related]
6. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?
Melzner WJ; Lotter M; Sauer R; Strnad V
Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy for T1-T2 floor-of-the-mouth cancers: the Gustave-Roussy Institute experience.
Marsiglia H; Haie-Meder C; Sasso G; Mamelle G; Gerbaulet A
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1257-63. PubMed ID: 11955737
[TBL] [Abstract][Full Text] [Related]
8. High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth.
Inoue T; Inoue T; Yamazaki H; Koizumi M; Kagawa K; Yoshida K; Shiomi H; Imai A; Shimizutani K; Tanaka E; Nose T; Teshima T; Furukawa S; Fuchihata H
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):53-8. PubMed ID: 9588917
[TBL] [Abstract][Full Text] [Related]
9. [Incidence of mandibular osteoradionecrosis in a series of 13 cases of carcinoma of the mouth floor].
Bouttier C; Perreau P; Bataini JP; Demaldent JE
Ann Otolaryngol Chir Cervicofac; 1990; 107(8):538-41. PubMed ID: 2085256
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
[TBL] [Abstract][Full Text] [Related]
11. Iodine-125 brachytherapy in the management of squamous cell carcinoma of the oral cavity and oropharynx.
Stannard C; Maree G; Tovey S; Hunter A; Wetter J
Brachytherapy; 2014; 13(4):405-12. PubMed ID: 24818781
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
[TBL] [Abstract][Full Text] [Related]
13. Osteoradionecrosis of the mandible. Comparison of the effects of external beam irradiation and brachytherapy.
Støre G; Evensen J; Larheim TA
Dentomaxillofac Radiol; 2001 Mar; 30(2):114-9. PubMed ID: 11313733
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.
Bachaud JM; Delannes M; Allouache N; Benchalal M; Alzieu C; David JM; Serrano E; Daly-Schveitzer NJ
Radiother Oncol; 1994 Jun; 31(3):199-206. PubMed ID: 8066202
[TBL] [Abstract][Full Text] [Related]
15. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.
Lapeyre M; Hoffstetter S; Peiffert D; Guérif S; Maire F; Dolivet G; Toussaint B; Mundt A; Chassagne JF; Simon C; Bey P
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):37-42. PubMed ID: 10924969
[TBL] [Abstract][Full Text] [Related]
16. Osteoradionecrosis of mandible bone in patients with oral cancer--associated factors and treatment outcomes.
Chen JA; Wang CC; Wong YK; Wang CP; Jiang RS; Lin JC; Chen CC; Liu SA
Head Neck; 2016 May; 38(5):762-8. PubMed ID: 25521838
[TBL] [Abstract][Full Text] [Related]
17. Mandibular osteoradionecrosis in squamous cell carcinoma of the oral cavity and oropharynx: incidence and risk factors.
Monnier Y; Broome M; Betz M; Bouferrache K; Ozsahin M; Jaques B
Otolaryngol Head Neck Surg; 2011 May; 144(5):726-32. PubMed ID: 21493361
[TBL] [Abstract][Full Text] [Related]
18. Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases.
Pernot M; Hoffstetter S; Peiffert D; Luporsi E; Marchal C; Kozminski P; Dartois D; Bey P
Radiother Oncol; 1995 Jun; 35(3):177-85. PubMed ID: 7480819
[TBL] [Abstract][Full Text] [Related]
19. Osteoradionecrosis of mandible in patients treated with definitive radiotherapy for carcinomas of oral cavity and oropharynx. A retrospective study.
Kumar HS; Bihani V; Kumar V; Chaudhary RK; Kumar L; Punia DP
Indian J Dent Res; 1992; 3(2):47-50. PubMed ID: 1343958
[TBL] [Abstract][Full Text] [Related]
20. Low-dose-rate interstitial brachytherapy preserves good quality of life in buccal mucosa cancer patients.
Tayier A; Hayashi K; Yoshimura R
J Radiat Res; 2011; 52(5):655-9. PubMed ID: 21768751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
